ICU · Toxicology
Alcohol withdrawal and delirium tremens
Also known as Alcohol withdrawal syndrome (AWS) · Delirium tremens (DTs) · Wernicke encephalopathy · CIWA-Ar scoring · Symptom-triggered therapy · PAWSS (Prediction of Alcohol Withdrawal Severity Scale) · Kindling phenomenon
Alcohol withdrawal symptoms typically begin 6-24 h after cessation/reduction of alcohol intake. Stages: minor withdrawal (tremor, anxiety, insomnia), seizures (12-48 h after last intake, in up to 15% of patients), hallucinosis (12-24 h, in 2-8%), delirium tremens (typically around 72 h; occurs in 3-5% of withdrawal patients — confusion, agitation, autonomic hyperactivity; untreated mortality can be as high as 50%). Pathophysiology: chronic ethanol down-regulates inhibitory GABA receptors and up-regulates excitatory NMDA receptors; abrupt cessation produces CNS hyperexcitability — the basis of seizures, hallucinosis and DTs. Management: benzodiazepines are the gold standard — symptom-triggered (scale-guided) dosing is favoured over fixed tapering; give thiamine before/with glucose; add phenobarbital (10-15 mg/kg IV weight-based loading) when benzodiazepines are insufficient; dexmedetomidine only as an adjunct for sympathetic overactivity.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Give THIAMINE before glucose — glucose metabolism consumes thiamine, precipitating Wernicke encephalopathy
- Delirium tremens = medical emergency (untreated mortality can be as high as 50%) — ICU admission, high-dose benzodiazepines
- Alcohol withdrawal seizures: do NOT routinely use phenytoin — benzodiazepines are treatment of choice
- High CIWA-Ar scores = severe withdrawal — escalate to high-dose IV benzodiazepine protocol or ICU
- Kindling phenomenon: every withdrawal episode lowers the threshold and worsens the next — escalate prophylaxis early
- Magnesium, folate and thiamine deficiency are common in alcohol use disorder — supplement alongside potassium correction (ICU bundle: thiamine 200-500 mg IV q8h, ~4-5 g magnesium, 400-1000 mcg folate)
- Hallucinosis (clear sensorium) vs DTs (altered sensorium) — the single best discriminator
- Lorazepam preferred over diazepam in hepatic failure — no active metabolites, less accumulation
Timeline and stages
Alcohol withdrawal timeline (click each)
Seizures
Generalised tonic-clonic seizures, typically 12-48 h after the last drink; occur in up to 15% of withdrawing patients. Benzodiazepines are the treatment of choice; anticonvulsants (carbamazepine, gabapentin) do not prevent seizures; phenytoin is an adjunct only for complications, not routine therapy.
| Stage | Onset (after last drink) | Hallmark | Sensorium | Frequency | Disposition |
|---|---|---|---|---|---|
| Minor withdrawal | 6-24 h (often within 8 h) | Tremor, anxiety, insomnia, nausea, sweating, tachycardia, hypertension | Clear | Most withdrawals | Ward/outpatient; benzodiazepine (fixed or symptom-triggered) |
| Withdrawal seizures | 12-48 h | Generalised tonic-clonic | Brief post-ictal only | Up to 15% of patients | Observe; benzodiazepines are treatment of choice |
| Alcoholic hallucinosis | 12-24 h | Visual typically more than auditory hallucinations | Clear — patient oriented | 2-8% of patients | Ward/HDU; benzodiazepine |
| Delirium tremens (DTs) | ~72 h | Confusion + agitation + autonomic storm + hallucinations | Altered — disoriented | 3-5% of patients | ICU — high-dose IV benzodiazepine ± intubation; untreated mortality up to 50% |
References18ShowHide
- [1]Sachdeva A, Choudhary M, Chandra M. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond J Clin Diagn Res, 2015.PMID 26500991
- [2]Lee CM, Dillon DG, Tahir PM, et al. Phenobarbital treatment of alcohol withdrawal in the emergency department: A systematic review and meta-analysis Acad Emerg Med, 2024.PMID 37923363
- [3]Donnino MW, Vega J, Miller J, et al. Myths and misconceptions of Wernicke's encephalopathy: what every emergency physician should know Ann Emerg Med, 2007.PMID 17681641
- [4]Amato L, Minozzi S, Davoli M. Benzodiazepines for alcohol withdrawal Cochrane Database Syst Rev, 2010.PMID 20238336
- [5]Mayo-Smith MF Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal JAMA, 1997.PMID 9214531
- [6]Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) Br J Addict, 1989.PMID 2597811
- [7]Rosenson J, Clements C, Simon B, et al. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study J Emerg Med, 2013.PMID 22999778
- [8]Meloy P, Rutz D, Bhambri A. Alcohol Withdrawal J Educ Teach Emerg Med, 2025.PMID 39926251
- [9]Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU Crit Care Med, 2016.PMID 27002274
- [10]Maldonado JR, Sher Y, Ashouri JF, et al. The Prediction of Alcohol Withdrawal Severity Scale (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome Alcohol, 2014.PMID 24657098
- [11]Wolpaw BJ, Oren H, Quinnan-Hostein L, et al. Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal JAMA Netw Open, 2025.PMID 40853658
- [12]Bahji A, Bach P, Danilewitz M, et al. Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis Addiction, 2022.PMID 35194860
- [13]Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy J Neurol Neurosurg Psychiatry, 1986.PMID 3701343
- [14]Muncie HL Jr, Yasinian Y, Oge' L. Outpatient management of alcohol withdrawal syndrome Am Fam Physician, 2013.PMID 24364635
- [15]Dingwall KM, Delima JF, Binks P, et al. What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial Alcohol Clin Exp Res, 2022.PMID 35428992
- [16]To DC, Steel TL, Carey KA, et al. Alcohol Withdrawal Severity Measures for Identifying Patients Requiring High-Intensity Care Crit Care Explor, 2024.PMID 38505174
- [17]Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome Am Fam Physician, 2004.PMID 15053409
- [18]Polintan ETT, Danganan LML, Cruz NS, et al. Adjunctive Dexmedetomidine in Alcohol Withdrawal Syndrome: A Systematic Review and Meta-analysis of Retrospective Cohort Studies and Randomized Controlled Trials Ann Pharmacother, 2023.PMID 36258676